中国全科医学2024，Vol.27Issue(36)：4493-4497,5.DOI:10.12114/j.issn.1007-9572.2024.0231
立足分级诊疗的血脂异常管控体系的建立与推广
Establishment and Promotion of a Dyslipidemia Management and Control System Grounded on Hierarchical Medical Treatment
摘要
Abstract
Dyslipidemia constitutes an essential risk factor for atherosclerotic disorders.From employing diverse types of blood lipid indicators as markers for risk prediction to subsequently applying low-density lipoprotein cholesterol as the primary lipid-lowering target in both primary and secondary prevention of cardiovascular diseases,relevant research and clinical practices indicate that the dyslipidemia management system grounded on hierarchical medical care is a significant measure for effective blood lipid control and efficient reduction of cardiovascular diseases.Continuously optimizing the prediction model for cardiovascular diseases,enhancing the construction of the medical consortium specializing in dyslipidemia disorders,and promoting the dyslipidemia management and control system based on hierarchical medical treatment will facilitate elevating the overall prevention and treatment level of dyslipidemia in China,and mitigate the health menace of cardiovascular diseases for Chinese residents.关键词
动脉粥样硬化性心血管疾病/血脂异常/分级诊疗/风险预测Key words
Atherosclerotic cardiovascular disease/Dyslipidemia/Hierarchical medical treatment/Risk prediction分类
医药卫生引用本文复制引用
张龙,李建平..立足分级诊疗的血脂异常管控体系的建立与推广[J].中国全科医学,2024,27(36):4493-4497,5.基金项目
国家重点研发计划(2021YFC2500600,2021YFC2500601) （2021YFC2500600,2021YFC2500601）
